The omega-3 fatty acid docosahexaenoic acid (DHA) is known as an anticancer agent. Colorectal cancer (CRC) cells exhibit different sensitivity toward DHA, but the mechanisms involved are still unclear. Gene expression profiling of 10 CRC cell lines demonstrated a correlation between the level of DHA sensitivity and different biological stress responses, such as endoplasmic reticulum (ER) stress, oxidative stress, and autophagy. The basal level of autophagy and MAP1LC3B-II protein correlated with DHA sensitivity in the cell lines studied. DHA induced oxidative stress, ER stress, and autophagy in DHA-sensitive DLD-1 cells, while the less sensitive LS411N cells were affected to a much lesser extent. Co-treatment with DHA and the autophagy inducer rapamycin reduced DHA sensitivity in DLD-1 and HCT-8 cells, while co-treatment with DHA and the autophagy inhibitors chloroquine and 3-methyladenine increased the DHA sensitivity in LS411N and LS513 cells. Differentially expressed genes correlating with DHA sensitivity and the level of autophagy demonstrated an overlap in biological pathways involved. Results indicate the basal level of autophagy and MAP1LC3B-II protein as potential biomarkers for DHA sensitivity in CRC cells.
Introduction
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diagnosed in 2012, of which 65% in highly developed countries [1] . Despite progress in early diagnosis and treatment (surgery, chemotherapy, and radiotherapy), CRC caused~770 000 deaths in 2015 [1, 2] . Lifestyle (alcohol, smoking) and diet (red/processed meat, fatty meals) are considered major risk factors [3] . However, increased physical activity and a diet rich in fruit, vegetables, fish, and white meat seem to decrease the risk [4] . Although epidemiological studies have been inconclusive, several in vitro, in vivo, and some clinical studies support the anticancer properties of the omega-3 polyunsaturated fatty acid (PUFA) docosahexaenoic acid (DHA, 22 : 6 n-3) [5] [6] [7] , which may represent a nontoxic and safe way in the prevention and management of cancer. Moreover, omega-3 PUFAs have been reported to increase the effect of several anticancer drugs [8, 9] . A variety of mechanisms explaining the anti-carcinogenic properties of DHA have been reported, such as oxidative stress, lipid peroxidation, and eicosanoid synthesis (reviewed in [10] ). We have previously shown that DHA induces endoplasmic reticulum (ER) stress, unfolded protein response (UPR), and growth arrest in several different colon cancer cells [11] . Our research group also found that one CRC cell line with low basal level of autophagy was more susceptible to treatment with DHA compared with another CRC cell line with higher basal autophagy level [6] . Both the UPR and autophagy signaling pathways are potential therapeutic targets for CRC. The ER is responsible for protein synthesis and folding, synthesis of lipids and sterols, and the maintenance of Ca²⁺ homeostasis in cells. Disturbances in any of these functions will induce ER stress and the UPR. As an immediate response to ER stress, PKR-like ER kinase (PERK) phosphorylates nuclear factor 2 (erythroid 2-like; NFE2L2/Nrf2) and eukaryotic translation initiation factor 2 alpha (eIF2a), thereby triggering the antioxidant defense system and inhibiting protein synthesis, respectively. Despite attenuation of protein translation, activating transcription factor 4 (ATF4) is translationally upregulated to activate the integrated stress response (ISR), which includes target genes involved in resistance to oxidative stress, differentiation, metastasis, angiogenesis, amino acid synthesis, drug resistance, apoptosis, and autophagy, and it is often found upregulated in tumors. However, not all genes regulated by ATF4 are associated with cell survival. If the ER stress is too severe, ATF4 induces proapoptotic genes, like TF C/EBP homologous protein (CHOP) [12, 13] . ATF4 also induces tribbles pseudokinase 3 (TRIB3), which often is found overexpressed in colon cancers and associated with poor prognosis [14] .
Recent studies have suggested the eIF2a-ATF4 pathway as an important regulator of many autophagy genes [15, 16] . Autophagy is a highly regulated catabolic process activated in response to different kinds of stresses like damaged organelles, nutrient deprivation, reactive oxygen species (ROS), anticancer agents, and protein aggregation [17] . Macroautophagy (hereafter referred to as autophagy) is initiated by the formation of an autophagosome that engulfs cellular components marked for degradation. The autophagosome fuses with a lysosome and the contents are degraded and recycled. Dysregulation of autophagy has been implicated in several diseases such as cancer, neurodegenerative diseases, cardiovascular diseases, and infectious and metabolic diseases [17] . The role of autophagy in cancer growth and development is complicated, having both a possible pro-survival and a death-inducing role.
A commonly used marker to monitor autophagy is microtubule-associated protein 1, light chain 3 beta (MAP1LC3B/LC3B) [18] . MAP1LC3B is post-translationally modified to the lipidated form, MAP1LC3B-II, that attaches to the inner autophagosomal membrane where it remains until it is degraded after fusion with the lysosome [19] . Autophagy may be selective, for example, through binding of ubiquitinated proteins and organelles to the scaffold protein sequestosome 1 (SQSTM1) [20, 21] .
The tumor suppressor protein p53 (TP53) is commonly found mutated in human cancers and contributes to disease progression and chemotherapy resistance. Mutant TP53 has increased stability, tends to accumulate in tumors, and often exerts oncogenic properties by promoting angiogenesis, invasion, migration, survival, and proliferation [22, 23] . TP53 also influences the autophagic process and may function both as a negative and positive regulator of autophagy depending on its subcellular localization. In the nucleus, TP53 increases autophagy by acting as a transcription factor trans-activating different autophagic inducers [24, 25] . Negative regulation occurs mainly via its cytoplasmic localization where even normal amounts of TP53 contribute to the suppression of autophagy, and the cytoplasmic level of TP53 has to be reduced to induce autophagy. Different cellular stresses known to trigger autophagy, including rapamycin, nutrient deprivation, and toxins, influence the degradation of TP53 [24] [25] [26] [27] .
We here report that gene expression profiling of 10 CRC cell lines demonstrated a correlation between DHA sensitivity and biological processes involved in the ISR. Accordingly, ER stress and oxidative stress were induced in the DHA-sensitive DLD-1 cells, but not in the less DHA-sensitive LS411N cells. TP53 has previously been suggested to mediate DHA-induced growth inhibition in cancer cells. Our results showed that DHA reduced the protein level and the positive nuclear staining of TP53 in DLD-1 cells. DHAinduced cytotoxicity seemed to be TP53 independent, since knock down of TP53 did not affect DHA sensitivity in these cells. However, we observed cytoplasmic aggregates positively stained for both TP53 and the autophagy marker MAP1LC3B-II in DLD-1 cells, indicating that autophagy was induced. Our results showed that DHA increased the autophagic flux in DLD-1, but not in LS411N cells. Also, DHA sensitivity correlated with the basal levels of autophagy and MAP1LC3B-II protein in the 10 different CRC cell lines. Extended gene expression analysis revealed that genes correlating with DHA sensitivity and basal autophagy level were enriched in biological processes such as oxidative stress, lipid metabolism and catabolism, and protein degradation. The results from this study indicate that the basal level of autophagy and MAP1LC3B-II protein may be used as potential biomarkers for DHA sensitivity in CRC cells.
Results
Differences in DHA sensitivity correlate with differences in gene expression in CRC cell lines Ten CRC cell lines, representing different clinically relevant CRC subtypes, were selected for gene expression analysis. Sensitivity towards DHA treatment (70 lM) was measured by cell counting and varied from~50% growth inhibition after 48 h for the most sensitive cell lines (DLD-1, SW480, and SW620) to almost no effect for the less sensitive cell lines (Caco-2, LS411N, LS174T, and LS513; Fig. 1A ).
Gene expression analysis was performed for the same 10 cell lines to search for pathways and mechanisms underlying the differences in DHA sensitivity. Data analysis yielded 339 probes significantly correlating with the level of DHA sensitivity (Fig. 1B) . The statistical model fitted the data well, and the expression levels of the three most significant genes, transmembrane serine protease 4 (TMPRSS4), dopa decarboxylase (DDC), and A-kinase anchoring protein 12 (AKAP12), have all been linked to the pathological state or prognosis of CRC (Fig. 1C ) [28] [29] [30] . Gene ontology (GO) enrichment analysis revealed probes representing genes belonging to several different biological pathways, such as vesicle-mediated transport, unsaturated fatty acid metabolism, response to lipid, regulation of response to stress, regulation of phosphorylation, regulation of programmed cell death, oxidation-reduction process, peroxisomes, ER membrane, and Golgi apparatus (Fig. 1D,E) . Examination of the gene list used for the GO analysis revealed several genes involved in regulation of ER stress, autophagy, lysosomal activity, protein metabolism, and oxidative stress (Table 1) . With regard to autophagy, it should be noted that GO term databases are not yet well enough annotated. Several genes with known functions in autophagy were, therefore, identified by manually inspection of gene lists. Among these was the DEP domain containing mechanistic target of rapamycin (mTOR)-interacting protein (DEPTOR), which is an inhibitor of mTOR, a wellknown regulator of autophagy. Hence, Table 1 is a selection of genes from the gene list that is known to be involved in the regulation of ER stress, oxidative stress, and autophagy.
DHA induces oxidative stress and ER stress in DHA-sensitive DLD-1 cells
Based on the gene expression results and our previous findings suggesting that cytotoxic effects of DHA are associated with ER stress in CRC cell lines [11] , we wanted to further examine the ISR in the DHAsensitive (DLD-1) and less sensitive (LS411N) cells ( Fig. 2A) . These cells were cultivated in the same growth media to exclude possible artifacts due to different culture conditions. Immunoblot analysis of total protein extracts from DLD-1 cells treated with DHA (70 lM) showed an upregulation of ER stress-related proteins, such as phosphorylated PERK and phosphorylated eIF2a at early time points (Fig. 2B) , which is considered a hallmark of ER stress. This was not observed in LS411N cells (Fig. 2B) . Phosphorylation of eIF2a leads to a general stop in translation, but increases the translation of certain proteins like ATF4, which was found upregulated in DHA-treated DLD-1 cells at all indicated time points (Fig. 2B) . ATF4 interacts with CHOP to induce TRIB3. Both CHOP and TRIB3 were found induced by DHA treatment in DLD-1 cells at time points indicated (Fig. 2B ). CHOP and TRIB3 increased slightly, although not significant, after 24 h with DHA treatment in LS411N cells (Fig. 2B) . The results were confirmed by confocal imaging demonstrating nuclear upregulation of ATF4, CHOP and TRIB3 in DLD-1 cells after incubation with DHA (70 lM) at indicated time periods (Fig. 2C) . The expression levels were further increased after treatment with DHA (105 lM). In LS411N cells, only TRIB3 was found to be slightly increased after treatment with DHA (105 lM) for 12 h. Knock down of ATF4 using siRNA reduced the growth of control cells, but did not affect the growth-inhibitory effect of DHA (Fig. 2D ). Prolonged ER stress may lead to activation of apoptosis, for example, through induction of CHOP [12] . However, examination of the protein poly (ADP-ribose) polymerase 1 (PARP1), which is known as a stress response modulator and is cleaved during apoptosis [31] , showed that PARP1 was not cleaved after DHA treatment in DLD-1 cells (Fig. 2B) .
Multiple lines of evidence indicate that ROS is involved in the DHA-mediated cytotoxicity in several cancer cells [32, 33] . To investigate the role of ROS in DHA-mediated growth inhibition, the effect of coincubation with DHA (70 lM) and different antioxidants was examined. DHA-treated DLD-1 and LS411N cells were co-incubated with butylated hydroxyanisole (BHA, 50 lM), butylated hydroxytoluene (BHT, 50 lM), vitamin E (50 lM), and n-acetyl cysteine (NAC, 1 mM) for 24 and 48 h before cell counting. BHT and vitamin E did not counteract the growthinhibitory effect of DHA in DLD-1 cells (Fig. 3B,C) , while BHA further increased the growth-inhibitory effect of DHA (Fig. 3A) . However, NAC, a potent ROS scavenger, counteracted the DHA-induced growth inhibition in DLD-1 cells by about 16% (Fig. 4A) .
The mitochondrial superoxide (MitoSOX) level was detected by flow cytometry using the fluorescent Mito-SOX probe. Results indicated a high increase in Mito-SOX in DLD-1 cells after DHA (70 lM) treatment, which increased further after co-incubation with DHA and NAC (Fig. 4B) . Only a slight increase in Mito-SOX level was observed in LS411N cells after DHA (70 lM) treatment (Fig. 4B) .
The fluorescent 5-(and-6)-Carboxy-2 0 ,7 0 -dichlorodihydrofluoresceindiacetate (DCF) probe was used to measure cellular ROS levels in DLD-1 and LS411N cells by flow cytometry (Fig. 4C) . Results clearly demonstrated an increased cellular ROS level in DLD-1 cells after 6-and 24-h incubation with DHA (70 lM; Fig. 4C) . The increased ROS level in DLD-1 cells was reduced when co-incubating the cells with DHA and NAC (1 mM; Fig. 4C) . The cellular ROS level in LS411N cells was not affected by the same treatment (Fig. 4C) .
Immunoblotting and confocal imaging indicated an induction of the antioxidant regulator NFE2L2 in DLD-1 cells after DHA (70 lM) treatment, which indicates induction of oxidative stress (Fig. 2B,C ). An induction of NFE2L2 was detected in LS411N cells upon DHA treatment, however, to a lesser extent compared with DLD-1 cells (Figs 2B,C and 4D).
Accumulation of unfolded proteins in the ER lumen may trigger the production of ROS, which induces the transcription of genes involved in the antioxidant defense through the PERK-mediated phosphorylation of NFE2L2 [34] . Therefore, cotreatment with DHA and NAC was performed to investigate whether it would affect the expression level of ER stress proteins. Indeed, co-treatment with NAC clearly reduced the DHA-mediated upregulation of ATF4, SQSTM1, and NFE2L2 in DLD-1 cells (Fig. 4D) . The same trend was observed, although to a lesser extent, in LS411N cells (Fig. 4D) .
DHA causes mutant TP53 to decrease and form aggregates in DLD-1 cells Previous studies have found DHA-mediated growth inhibition to be TP53 dependent in cancer cells harboring wt TP53 [35, 36] , while others have found TP53 independent pathways induced by DHA in cancer cells with mutant TP53 gene and no detectable protein [32] . When present, TP53 seems to play a central role in DHA-mediated cytotoxicity [37] . Since there are several variants of mutant TP53 present in different types of cancers, the role of TP53 in DHA-mediated growth inhibition probably changes with cell type and mutational status. DLD-1 cells harbor a mutant TP53 (p.S241F) with a high level of detectable TP53 protein, while LS411N cells have a mutated TP53 gene (p.Y126) which gives a truncated nondetectable TP53 protein [38, 39] . Results from immunoblot analysis showed that the protein level of TP53 in DLD-1 cells decreased after 12-and 24-h incubation with DHA (70 lM), and this reduction was counteracted by NAC (Fig. 5A) .
Confocal imaging indicated that TP53 was mainly localized in nucleus in DLD-1 control cells (Fig. 5B) . DHA treatment reduced the positive nuclear staining of TP53 and induced cytoplasmic aggregates positively stained for TP53 (Fig. 5B) . Co-incubation with DHA and NAC increased the number of nuclei positively stained for TP53 compared with DHA-treated cells, 25% of DHA-treated DLD-1 cells had positive staining for TP53 in the nuclei, compared with 42% after co-treatment with NAC (Fig. 5B) .
TP53 is known as an autophagy regulator [24] , and we wanted to investigate the localization of cytoplasmic TP53 aggregates relative to the localization of MAP1LC3B in DLD-1 cells after DHA (70 lM) supplementation. Figure 5B indicates a colocalization of TP53 and MAP1LC3B aggregates in DHA-treated DLD-1 cells. Treatment with bafilomycin A1 (BafA1), an autophagy inhibitor, did not cause TP53 aggregation. Also, bafA1 alone or in Enriched GO terms in the 'molecular function' and 'cellular compartment' categories for probes with significant positive (Pos Sensitivity; logFC > 0 from B) and negative (Neg Sensitivity; logFC < 0) correlation to DHA sensitivity levels in the 10 cell lines tested. The color coding reflects level of statistical significance (Àlog10 adj. P-value), and the size of the circles the odds ratio as calculated by the Fisher's exact test. (E) Enriched GO terms in the 'biological process' category for probes with significant positive (Pos Sensitivity; logFC > 0 from B) and negative (Neg Sensitivity; logFC < 0) correlation to DHA sensitivity levels in the 10 cell lines tested. The color coding reflects level of statistical significance (Àlog10 adj. P-value), and the size of the circles the odds ratio as calculated by Fisher's exact test. 5C ).
DHA increases the autophagic flux in DLD-1 cells
Endoplasmic reticulum and oxidative stress are known to be inducers of autophagy (reviewed in [40] ). To investigate the effect of DHA on the level of autophagy in DLD-1 and LS411N cells, the amount of autophagic vacuoles was measured using the fluorescent autophagic marker Cyto-ID. The level of autophagic flux was determined by comparing cells coincubated with DHA and BafA1 with cells supplemented with BafA1 alone. MAP1LC3B is necessary for the elongation of the autophagosome. The amount of the lipidated form, MAP1LC3B-II, correlates with the amount of autophagosomes and is commonly used as an indicator of autophagosome formation. Our results show that DHA treatment induces autophagic flux in DLD-1 cells, but not in LS411N cells (Fig. 6A , B,C). Confocal imaging indicated an increase in both SQSMT1 and MAP1LC3B upon DHA treatment for 12 and 24 h in DLD-1 cells. Similarly, when co-incubating with BafA1 and DHA, an increased induction of SQSTM1 and MAP1LC3B was observed in comparison with BafA1 alone (Fig. 6A) . The protein level of SQSTM1 and MAP1LC3B seems to be higher in LS411N cells compared with DLD-1 cells, but the level of these proteins was not affected by any of the treatments (Fig. 6A ). Immunoblot analysis of both cell lines were performed after treatment with DHA (70 lM), with or without BafA1 (100 nM). Results demonstrated an increased autophagic flux in DLD-1 cells in response to DHA incubation (12 and 24 h), while the level of MAP1LC3B-II was reduced in LS411N cells after the same treatment (Fig. 6B) . The increased level of SQSTM1 in both cell lines after DHA treatment is most likely due to increased cellular . Flow cytometry using the Cyto-ID probe to stain autophagic vacuoles also showed an increased level of autophagy upon DHA treatment in DLD-1 cells (Fig. 6C) . NAC reduced the autophagic flux induced by DHA in DLD-1 cells, as demonstrated by confocal imaging, immunoblotting, and the Cyto-ID assay (Fig. 6A,B,C) . (Fig. 7F) . The protein level of MAP1LC3B-II was increased by rapamycin and to an even higher level after co-treatment with rapamycin and DHA (Fig. 7F) . The less DHA-sensitive LS411N and LS513 cells were incubated with DHA (140 lM), chloroquine (40 and 80 lM), 3-MA (3 mM), or a combination of DHA and one of these autophagy inhibitors. The results demonstrate that inhibition of autophagy significantly increased the DHA sensitivity in these two cell lines (Fig. 7G,H) . A higher concentration of DHA (140 lM) was used for LS411N and LS513 cells in order to detect the effect on cell number, while 70 lM DHA was used for the immunoblots. The protein level of MAP1LC3B-II was increased by treatment with either chloroquine or 3-MA in these cells; after co-treatment with chloroquine/3-MA and DHA (70 lM), the protein level of MAP1LC3B-II decreased significantly (Fig. 7G,H) . These results indicate that DHA induces autophagic flux in DHAsensitive cell lines (DLD-1 and HCT-8), while the autophagic flux is decreased by DHA in less sensitive cell lines (LS411N and LS513) . The autophagy level in these cells, measured by flow cytometry and the fluorescent Cyto ID probe, was affected in line with these results after the same treatment (Fig. 7I) .
Gene expression profile correlates with both DHA sensitivity and basal autophagy level Gene expression data were analyzed for correlation with scaled basal autophagy levels, revealing 1268 probes to be significantly correlated ( Fig. 8A ; adjusted P-value 0.05). Of these, 309 also correlated with scaled DHA sensitivity levels. Although autophagy and sensitivity measurements were highly correlated between the cell lines, they still differed. Therefore, we investigated whether differences between autophagy and DHA sensitivity could be explained by certain genes. Accounting for residuals in the analysis extended the list of significantly correlating probes for both DHA sensitivity and autophagy ( Fig. 8B; 637 and 1345 probes, respectively). The expression of 608 probes correlated with both in this analysis. GO term enrichment analysis clearly shows an overlap in the represented biological processes and cellular compartment between probes correlating with DHA sensitivity and those correlating with the basal autophagy level (Fig. 8C,D) . Among overlapping GO terms for biological process were 'lipid homeostasis', 'oxidationreduction process', 'cellular lipid catabolic process' and 'unsaturated fatty acid metabolic process'. Overlapping GO terms for cellular compartment were, for example, 'golgi apparatus', 'ER membrane', 'peroxisome', 'endosome' and 'lysosome'. No significantly enriched terms were found for the probes representing residuals in the linear model, that is, the probes that can better be described by one process and not the other.
Autophagy was not among the enriched terms for significant probes, with an adjusted P-value of 1. Only 21 probes belonging to the GO category for autophagy (GO:0006914) and its children significantly correlated with scaled basal autophagy or DHA sensitivity levels, for example, the probes for ATP1B1 and USP13 (Fig. 8E ). However, we found genes known to be involved in the regulation of autophagy with significant correlation that were both listed and not listed in the GO category for autophagy, including AKT3 and DEPTOR (Fig. 8E) .
Discussion
Marine omega-3 fatty acids, such as DHA, have been shown to have anticancer properties. We and others have studied the mechanisms behind this anticancer effect mainly based on observations from a few cancer cell lines. The fact that some cancer cells are sensitive to DHA, while others are not, needs special attention. The relevance of cancer cell lines as preclinical models is often questioned, since in vitro culturing fails to maintain the natural microenvironment of cells. Also, cancer patients often have heterogeneous genetic features implying that a large number of cell lines needs to be analyzed in order to mimic the molecular heterogeneity in patients. Medico et al. [41] have analyzed a collection of 151 CRC cell lines by mutational and transcriptional profiling, and discovered that the molecular subtypes of CRC in patients are maintained in the cell lines. They conclude that genetic and pharmacological profiling of CRC cell lines can be used in search for clinically relevant biomarkers for targeted treatment response.
In search for a potential biomarker for DHAinduced cytotoxicity, we selected 10 CRC cell lines representing five clinically relevant CRC subtypes [42] that differed in sensitivity to DHA treatment (Fig. 1A) . Gene expression profiling indicated a correlation between the expression of genes involved in the regulation of different biological processes, like response to autophagy, ER stress (UPR) and oxidative stress, and DHA sensitivity in the 10 cell lines (Fig. 1E and Table 1 ). These biological processes are part of the ISR and were found to be induced by DHA treatment in DHA-sensitive DLD-1 cells (Figs 2B,C, 4A, and 6A,B), confirming previous results by our research group and others [6, 11, 37] . Interestingly, co-treatment of the DHA-sensitive DLD-1 cells with the antioxidant NAC reduced the DHA-induced growth inhibition, cellular oxidative stress, and protein level of NFE2L2 and ATF4 (Fig. 4A,C,D) . These results suggest an interconnection between the ER and oxidative stress signaling pathways in response to DHA treatment in this cell line. The tumor suppressor protein TP53 is known to be mutated in over 40% of colorectal tumors [43] . The TP53 status is different between DLD-1 and LS411N cells; DLD-1 cells express a mutated form of TP53 protein, while the TP53 mutation in LS411N cells results in no TP53 expression. It has previously been shown that DHA treatment of cancer cells initially escalates TP53 protein level, before it decreases [37, 44] , which is in accordance with our results (Fig. 5A) . However, our results also demonstrate that the number of nuclei positive for TP53 decreases and aggregates are formed in the cytoplasm after DHA treatment. This effect was partly counteracted by NAC (Fig. 5B) . Cytoplasmic aggregation of mutant TP53 in cancer cells followed by induction of heat shock protein 70 (HSP70) has previously been demonstrated [45] . HSP70 is commonly induced by ER stress, which corresponds with our previous finding in DHAsensitive SW620 colon cancer cells [6] .
Endoplasmic reticulum and oxidative stress, as well as several other stressful conditions, affect the expression of TP53 and the level of autophagy (reviewed in [40] ). TP53 is known to affect the autophagic process both as positive and negative regulator, depending on its localization. In the nucleus, TP53 activates autophagy-stimulating genes, while cytoplasmic TP53 inhibits autophagy (reviewed in [40] ). When co-incubating the DHA-sensitive DLD-1 cells with antibodies for both TP53 and the autophagy marker protein MAP1LC3B, both aggregated in the cytoplasm upon DHA treatment, suggesting that MAP1LC3B and TP53 aggregates colocalize upon DHA treatment (Fig. 5B) . Interestingly, co-treatment of DLD-1 cells with DHA and NAC partly counteracted the decrease in TP53 protein level (Fig. 5A) . Knock down of TP53 strongly reduced growth of the DLD-1 control cells, but failed to influence the DHA sensitivity, suggesting that the expression of TP53 is important for the cell growth. However it probably does not play an important role in the DHAmediated growth inhibition in DLD-1 cells (Fig. 5C ). These results are in accordance with findings from Shin et al. (2013) , who demonstrated that DHA reduced cell viability independent of TP53 status [37] .
Our results clearly demonstrate that DHA treatment enhanced the autophagic flux in the DHA-sensitive DLD-1 cells (Fig. 6A,B,C) . The autophagic flux was subsequently reduced upon treatment with the antioxidant NAC, which is in accordance with previous studies [6, 37, 44, 46] . Further elucidation of the role of autophagy related to DHA sensitivity in the 10 human CRC cell lines revealed that these cell lines have significantly different basal level of autophagy (Fig. 7A) . Previous results from our group indicated the importance of the basal level of autophagy in two CRC cell lines differing in DHA sensitivity, which is clearly supported by the more comprehensive experiments presented here. Correlation analysis provided a strong correlation between basal autophagy level and DHA sensitivity (Fig. 7C) . Other studies have shown that the autophagy level in cells may be important for their response/resistance to different chemotherapeutic agents (reviewed in [47] ). Autophagy may have a dual role in its interaction with anticancer drugs. Induction of autophagy-mediated cell death may enhance the anticancer drug efficiency in some cancers [48] , although it is more common that autophagy increases cancer cell survival by contributing to the development of drug resistance. Autophagy-mediated drug resistance is probably a cell-protective mechanism against the cytotoxic effect of anticancer drugs, promoting cancer cell survival. Several studies have demonstrated that inhibition of autophagy enhances the effect of chemotherapy in CRC [49] [50] [51] , which makes it a promising therapeutic target to overcome drug resistance and thereby increasing the effect of different anticancer therapies.
Induction of autophagy by rapamycin reduced DHA sensitivity in DLD-1 and HCT-8 cells (Fig. 7F) , while autophagy inhibitors, chloroquine and 3-MA, increased the DHA sensitivity of LS411N and LS513 cells (Fig. 7G,H) . The significant effect of 3-MA on DHA sensitivity needs to be further examined to find the underlying mechanism; however, some studies have indicated the relevance of the PI3K/AKT/mTOR signaling pathway in omega-3 fatty acid-mediated growth inhibition of cancer cells [37, 46] .
The protein level of the lipidated form of MAP1LC3B (MAP1LC3B-II), a commonly used marker to monitor autophagy, was found to correlate with the degree of DHA sensitivity (Fig. 7B,D) . Hence, the MAP1LC3B-II protein level was lower in the most DHA-sensitive cell lines, which is in accordance with our previous results [6] . Adams et al. [52] explored the prognostic relevance of MAP1LC3B and SQSTM1 in esophageal adenocarcinomas (EAC) and demonstrated that low MAP1LC3B and SQSTM1 protein levels correlated with worse outcome and more aggressive tumors in a cohort of patients with EAC. In line with this, patients with tumors with low MAP1LC3B-II levels could potentially benefit from an alternative treatment strategy with omega-3 fatty acids in combination with conventional cancer treatment. Intratumor heterogenic expression patterns of proteins may occur. However, Adams et al. [52] found that most of the studied EACs had homogenous MAP1LC3B staining patterns across tumors, and Niklaus et al. [53] found that primary resected colon cancer tissue stained for MAP1LC3B did not show significant intratumoral heterogeneity.
In cancer, autophagy has dual roles and can act as both a tumor promoter and a tumor suppressor. Autophagy protects against the development and progression of cancers by removing damaged organelles, ROS, and protein aggregates, while promoting carcinogenesis by providing increased amounts of available nutrients, enhancing drug resistance and inhibiting cell death [54] . Autophagy is known to be influenced by the ingredients of the growth media, for example, the amino acid content. By using the same culture media for the cell lines DLD-1, LS411N, HCT-8, and LS513, the potential influence of different media constituents on the autophagy process was excluded. Accordingly, natural variance in basal autophagy and MAP1LC3B-II protein between cancer cells seems likely. However, this has to be confirmed in tumor samples from a patient cohort.
Omega-3 fatty acids have been shown to improve the effect of different chemotherapeutic drugs (reviewed by [8, 55] ). The understanding of how genetic differences in CRC affect nutrient metabolism is a highly relevant nutrigenomic approach that may translate into recognition of new biomarkers potentially improving CRC treatment regimens. Next-generation sequencing of CRC cell lines and patient tumors could help us to further explore the potential application of DHA in personalized treatment/diets for CRC patients, in combination with conventional cancer treatment.
Materials and methods

Cell lines, culture conditions, and reagents
The 10 human CRC cell lines DLD-1, LS411N, LS513, HCT8, Lovo, LS174T, HT29, Caco-2, SW620, and SW480 were obtained from the American Type Culture Collection (ATCC; Rockville, MD, USA). DLD-1, LS411N, LS513, and HCT8 cells were grown in RPMI 1640 medium (Gibco, England, A10491-01), supplemented with 10% FBS (10270-098; Gibco) and gentamicin (Gibco, 15710049 
Cell treatment and assessment of growth inhibition
The effect of DHA and different antioxidants were investigated by cell counting. Twenty-four hours after seeding, DHA (70 lM), BHA (50 lM), BHT (50 lM), vitamin E (50 lM), NAC (1 mM), BafA1 (0.1 lM), 3-MA (3 mM), chloroquine (40 and 80 lM), rapamycin (50 nM), EtOH (vehicle), or HBSS were added to preheated growth medium to final concentrations as described. Cells were treated for indicated time periods before trypsination and resuspension in growth medium. The effect of the different treatments was assessed by cell counting using Moxi z mini automated cell counter (ORFLO Technologies, Ketchum, ID, USA).
Antibodies and immunoblot analysis
Cells were harvested at different time points after treatment, and total protein was isolated. The medium was removed and the cells were washed twice with ice-cold PBS, before scraping in cold PBS. The cells were lysed using a buffer containing UREA (8 M; Merck Millipore, Darmstadt, Germany, 1084870500), Triton-X100 (0, 5%; Sigma, T8787), DTT (100 nM), CompleteÒ protease inhibitor (Roche, Mannheim, Germany, 1187350001), and phosphatase inhibitor cocktail II and III (Sigma, P5726 and P0044). The concentration of the proteins was determined using the Bio-Rad assay (Bio-Rad, Hercules, CA, USA, 500-0006 
Measurement of intracellular ROS
The fluorescent-based ROS detection kit Image-iT TM LIVE Green ROS Detection Kit (Life Technologies, C6827) was used to measure the cellular level of ROS, and MitoSOX TM (Life Technologies, M36008) was used to measure the cellular level of MitoSOX, according to the supplier's instructions. DLD-1 and LS411N cells were treated with DHA (70 lM) and/or NAC (1 mM) for 6 and 24 h and co-incubated with DCF (0.3 lM) or Mito-SOX TM (5 lM) for 30 min before measuring intracellular ROS and MitoSOX, respectively. Fluorescence was measured using a BD fluorescence-activated cell sorting (FACS) Canto flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA).
Detection of autophagy levels by flow cytometry
Both changes in autophagic flux in response to DHA treatment in DLD-1, HCT-8, LS513, and LS411N cells and the basal level of autophagy of 10 different human CRC cell lines were measured using the Cyto-ID autophagy detection kit (Enzo Life Sciences, ENZ-51031-K200) according to the manufacturer's instructions. The cells were given various treatments, trypsinated, and stained with Cyto-ID detection agent for 30 min. The intensity of fluorescence per cell was determined using a BD FACS Canto flow cytometer and analyzed using the FCS Express 5 Plus Research Edition (De Novo Software, Glendale, CA, USA). The optical readings from Cyto-ID experiments were log2 transformed before performing Pearson correlation analysis using Microsoft excel.
Immunostaining and confocal imaging DLD-1 and LS411N cells were seeded in chamber slides (Nunc TM , 734-2062) and received appropriate treatments as specified for indicated time periods. The cells were fixed using 4% paraformaldehyde (Alfa Aesar, Haverhill, MA, USA, 43368.9 M) before staining with primary antibodies and appropriate fluorescently labeled secondary antibodies for visualization. DRAQ 5 (5 lM; BioStatus ltd, Loughborough, England, DR50200) was used as nuclear DNA marker. An Axiovert200 microscope equipped with a 63 9 1.2 W objective and the confocal module LSM510 META (Carl Zeiss, Oberkochen, Germany) were used to visualize the immunostaining. Images were processed using the LSM software (Carl Zeiss) and mounted using Canvas 15 (ACD Systems, Plantation, FL, USA).
siRNA-mediated knockdown of ATF4 and TP53
DLD-1 cells were seeded and transfected using ATF4 (Qiagen, SI03019345, 20 nM) and TP53 (Qiagen, SI00011655, 10 nM) specific siRNAs, negative control siRNA oligo, and Lipofectamine RNAiMax transfection buffer (Invitrogen, 13778075) for 48 h, following the manufacturer's protocol (Fischer Scientific). Cells were then trypsinized, seeded, and cultivated for 24 h before supplemented with vehicle or DHA. Proteins were isolated and cells were counted after 24-and 48-h incubation.
Gene expression profiling
Untreated cells were harvested by scraping in ice-cold PBS 48 h after seeding. RNA was isolated using the High Pure Isolation Kit (#11828665001; Roche) before quantification and quality control using NanoDrop and BioAnalyzer. Expression profiling was performed in duplicate experiments using the Human Genome U133 Plus 2.0 array from Affymetrix (Santa Clara, CA, USA) following standard procedures. Protocol and data have been submitted to ArrayExpress with accession number E-MTAB-5750.
Gene expression data analysis
All data analysis was conducted in R unless otherwise specified (http://r-project.org). We analyzed the microarray data using the Affy and Limma packages from BioConductor [56, 57] . The raw expression values (CEL files) were adjusted using the 'expresso' function with 'rma' background correction, quantile normalization, and 'medianpolish' summarization. The normalized data were fit to a linear model using scaled DHA sensitivity growth restriction values in Limma with the duplicateCorrelation function to account for the replicates. Pearson correlation value between the expression values for each probe and the scaled DHA-sensitivity growth inhibition values was calculated. The data were fit to a linear model using scaled Cyto-ID autophagy values in the same manner. Extended Limma analyses were performed with residuals from autophagy as a third coefficient for the sensitivity regression, and the residuals from sensitivity as a third coefficient for autophagy regression. Resulting P-values were adjusted using the Benjamini-Hochberg method, and a threshold of 0.05 for selection of genes fitting the models. The gProfileR tool [58] was used to analyze for overrepresented GO terms, and the 'analytical' setting was used for multiple testing correction. The odds ratio for each term was calculated using the Fisher's exact test. Only terms that contained a maximum of 1500 genes were included. Redundant terms were eliminated using the minimal set function in the ontologyIndex package [59] . Where specified, we ran an additional filter to select term names containing the following key words: 'lipid', 'oxidative', 'oxidation', 'vesicle', 'stress', 'protein metabolic', 'autophagy', 'protein catabolic', 'unfolded protein', and 'fatty acid'.
